ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 152 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $190,000 | -59.2% | 148,792 | +10.1% | 0.00% | -75.0% |
Q2 2019 | $466,000 | +64.1% | 135,092 | +141.3% | 0.00% | +33.3% |
Q1 2019 | $284,000 | +40.6% | 55,992 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $202,000 | -20.2% | 55,992 | +29.9% | 0.00% | 0.0% |
Q3 2018 | $253,000 | – | 43,092 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 3,278,000 | $11,834,000 | 0.90% |
Senvest Management, LLC | 2,124,393 | $7,669,000 | 0.66% |
DELTEC ASSET MANAGEMENT LLC | 351,176 | $1,268,000 | 0.35% |
PERKINS CAPITAL MANAGEMENT INC | 99,600 | $360,000 | 0.28% |
Matarin Capital Management, LLC | 838,619 | $3,027,415,000 | 0.24% |
GLOBEFLEX CAPITAL L P | 196,357 | $709,000 | 0.17% |
Opaleye Management Inc. | 120,000 | $433,000 | 0.16% |
TSP Capital Management Group, LLC | 49,175 | $178,000 | 0.10% |
Spark Investment Management LLC | 373,609 | $1,348,000 | 0.09% |
Connor, Clark & Lunn Investment Management Ltd. | 3,191,964 | $11,523,000 | 0.08% |